Maxamine histamine dihydrochloride histamine receptor agonist regulatory update

The FDA's Oncologic Drugs Advisory Committee (ODAC) unanimously recommended against approval of Maxamine

Read the full 139 word article

How to gain access

Continue reading with a
two-week free trial.